Status:
RECRUITING
Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
20-90 years
Phase:
PHASE4
Brief Summary
Aim: Therefore, we aimed to 1. compare the efficacy of susceptibility testing guided therapy vs. empirical therapy in the third-line eradication for refractory H. pylori infection 2. assess the long-...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Adult (equal or greater than 20 years old) patients who failed from at least two eradication therapies for H. pylori infection will be enrolled.
Exclusion
Key Trial Info
Start Date :
July 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04332848
Start Date
July 28 2020
End Date
December 1 2026
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 10002